Comparison of Hemostatic Efficacy of Argon Plasma Coagulation with and without Distilled Water Injection in Treating High-Risk Bleeding Ulcers

Table 2

Clinical outcomes of the study population.

	Combined group; ( = 60)	APC group; ( = 60)	value
Initial hemostasis	59 (98.3%)	57 (95.0%)	0.619
30-day rebleeding	2 (3.4%)	7 (12.3%)	0.092
Rebleeding time
Within 3 days	2 (3.4%)	6 (10.6%)
Between 4th and 30th days	0 (0%)	1 (1.8%)
Ulcer character
Spurting	0 (0%)	1 (1.8%)
Oozing	1 (1.7%)	3 (5.3%)
NBVV	1 (1.7%)	2 (3.5%)
Adherent clot	0 (0%)	1 (1.8%)
Surgery	1 (1.7%)	5 (8.3%)	0.207
Blood transfusion, unit (SD)	4.3 ± 4.2	3.6 ± 2.7	0.306
Hospital stay, day (SD)	6.6 ± 4.5	5.7 ± 2.9	0.219
30-day mortality (SD)	1 (1.7%)	2 (3.3%)	1.000
Uncontrollable bleeding	0 (0%)	2 (3.3%)
Septic shock	1 (1.7%)	0 (0%)
Treatment failure	3 (5.0%)	10 (16.7%)	0.040

*Treatment failure included initial treatment failure, rebleeding, surgery, and mortality.